• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Cybin Announces Overnight Marketed Public Offering of Common Shares firstwordpharma
    July 28, 2021
    Cybin Inc. is pleased to announce that it has launched an overnight marketed public offering of common shares in the capital of the Company (the "Shares") at a price per Share and for aggregate gross proceeds to be determined in the context of the market.
  • Cybin to Leverage Catalent’s Zydis for Psychiatric Drug contractpharma
    March 23, 2021
    To apply Zydis orally disintegrating tablet (ODT) technology for delivery of Cybin’s potential therapy for treatment-resistant psychiatric disorders.
  • CYBIN signs agreement to acquire Adelia Therapeutics pharmaceutical-business-review
    December 10, 2020
    Cybin announced the signing of a definitive agreement to acquire 100% of the shares in Adelia Therapeutics Inc. for up to CDN$20,161,575 (approximately $15.75m) in an all-stock transaction.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service